T0	Outcomes 1117 1151	Sustained virologic response (SVR)
T1	Outcomes 1345 1364	cohort, SVR24 rates
T2	Outcomes 1461 1480	cohort, SVR24 rates
T3	Outcomes 1556 1570	The SVR24 rate
T4	Outcomes 1643 1666	between SVR12 and SVR24
T5	Outcomes 1716 1736	were nasopharyngitis
T6	Outcomes 1743 1755	and headache